Vipshop Holdings Ltd/ US92763W1036 /
10/06/2024 21:59:59 | Var. +0.09 | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
16.20USD | +0.56% | 122,382 Fatturato: 1.98 mill. |
-Quantità in denaro: - | -Quantità in lettera: - | 16.32 | 15.99 |
GlobeNewswire
13:18
MRNS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Clas...
GlobeNewswire
13:15
AppTech Payments Announces Strategic Partnership with FISB Solutions to Upgrade Legacy Banking Syste...
GlobeNewswire
13:05
Kraig Biocraft Laboratories Announces Production Update for BAM-1 Spider Silk Hybrids
GlobeNewswire
13:05
Banks are making climate commitments, but are they actually making a difference?
GlobeNewswire
13:03
New Report From Meltwater and Asana Reveals Disconnect Between Marketing Goals and Business Objectiv...
GlobeNewswire
13:00
Lithium Ionic Completes Acquisition of Remaining 15% of Salinas Properties, Minas Gerais, Brazil
GlobeNewswire
13:00
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic A...
GlobeNewswire
13:00
Simply Good Foods to Report Third Quarter Fiscal Year 2024 Financial Results on Thursday, June 27, 2...
GlobeNewswire
13:00
Republic enhances tokenized asset accessibility with Zero Hash's fiat and USDC payment rails
GlobeNewswire
13:00
Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule ...
GlobeNewswire
13:00
Almaden to Pursue International Arbitration Against Mexico; Moves to Drop Mexican Lawsuits
GlobeNewswire
13:00
PyroGenesis Signs Contracts Totaling $2.5 Million to Deliver Greenhouse Gas-Reducing System for Majo...
GlobeNewswire
13:00
ZeroFox Named Winner of the Global InfoSec Awards and Cybersecurity Excellence Awards
GlobeNewswire
13:00
Akero Therapeutics Announces Initiation of Phase 3 SYNCHRONY Outcomes Trial of Efruxifermin in Patie...